Drug survival of systemic immunosuppressive treatments for atopic dermatitis in a long-term pediatric cohort
Background: : Systemic immunosuppressive treatments are central in the treatment of severe atopic dermatitis (AD). Yet, comparative data are sparse on the performance of such immunosuppressive treatments in pediatric cohorts with severe AD. Objective: : This study aimed to examine the drug survival...
Saved in:
Main Authors: | Stine Elsgaard, MBBS (Author), Anna Kathrine Danielsen, MBBS (Author), Jacob P. Thyssen, MD, PhD, DMSc (Author), Mette Deleuran, MD, DMSc (Author), Christian Vestergaard, MD, PhD, DMSc (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Botulinum toxin A versus microwave thermolysis for primary axillary hyperhidrosis: A randomized controlled trialCapsule Summary
by: Gabriela Lladó Grove, MD, et al.
Published: (2024) -
Adverse events from topical corticosteroid use in chronic hand eczema - Findings from the Danish Skin CohortCapsule Summary
by: Alexander Egeberg, MD, PhD, DMSc, et al.
Published: (2024) -
Therapeutic education in atopic dermatitis: A position paper from the International Eczema CouncilCapsule Summary
by: Lawrence F. Eichenfield, MD, et al.
Published: (2021) -
Risk factors that limit use of oral JAK inhibitors in chronic hand eczema: Findings from the Danish Skin CohortCapsule Summary
by: Yuki M.F. Andersen, MD, PhD, et al.
Published: (2024) -
Side effects after artificial hair implants: 2 case reports
by: Charlotte Näslund-Koch, MD, et al.
Published: (2020)